Bone Biologics Corp — Director's Dealing 2019

Mar 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2018-12-17

Reporting Person: Hankey Don (Director, Chairman of the Board, 10% Owner)
Reporting Person: HANKEY CAPITAL, LLC (10% Owner)
Reporting Person: Don Hankey Trust (affiliate of 10% owner/dir)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-17	Common Stock	P	18009696	—	Acquired	24210421	Indirect
2019-03-25	Common Stock	P	1489362	—	Acquired	25699783	Indirect

Footnotes

F1: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest.

F2: Mr. Hankey is the beneficial owner of 25,699,783 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 20,638,298 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital.